Hyppää sisältöön
    • Suomeksi
    • In English
  • Suomeksi
  • In English
  • Kirjaudu
Näytä aineisto 
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
JavaScript is disabled for your browser. Some features of this site may not work without it.

Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity Cohort

Kira Hongell; Alberto Ascherio; Merja Soilu-Hänninen; Julia Åivo; Heljä-Marja Surcel; Kassandra L. Munger

Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity Cohort

Kira Hongell
Alberto Ascherio
Merja Soilu-Hänninen
Julia Åivo
Heljä-Marja Surcel
Kassandra L. Munger
Katso/Avaa
Final draft (400.9Kb)
Lataukset: 

American Medical Association
doi:10.1001/jamaneurol.2015.4800
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2021042714930
Tiivistelmä


IMPORTANCE Vitamin D has been associated with a decreased risk of multiple sclerosis (MS)

in adulthood; however, some, but not all, previous studies have suggested that in utero

vitamin D exposure may be a risk factor forMS later in life.

OBJECTIVE To examine whether serum 25-hydroxyvitamin D (25[OH]D) levels in early

pregnancy are associated with risk of MS in offspring.

DESIGN, SETTING, AND PARTICIPANTS Prospective, nested case-control study in the Finnish

Maternity Cohort conducted in May 2011.We identified 193 individuals with a diagnosis of MS

before December 31, 2009, whose mothers are in the Finnish Maternity Cohort and had an

available serum sample from the pregnancy with the affected child.We matched 176 cases

with 326 controls on region of birth in Finland, date of maternal serum sample collection,

date of mother’s birth, and date of child’s birth.

MAIN OUTCOMES AND MEASURES Maternal serum 25(OH)D levelswere measured using a

chemiluminescence assay. The risk of MS among offspring and association with maternal

25(OH)D levels were the main outcomes. Conditional logistic regression was used and further

adjusted for sex of the child, gestational age at the time of sample collection, and season of

sample collection to estimate the relative risks and 95%CIs.

RESULTS Of the 193 cases in the study, 163 were female. Of the 331 controls in the study,

218 were female. Seventy percent of serum samples were collected during the first trimester

of pregnancy. The mean (SD) maternal vitamin D levels were in the insufficient vitamin D

range, but higher in maternal control than case samples (15.02 [6.41] ng/mL vs 13.86 [5.49]

ng/mL [to convert to nanomoles per liter, multiply by 2.496]). Maternal vitamin D deficiency

(25[OH]D levels <12.02 ng/mL) during early pregnancy was associated with a nearly 2-fold

increased risk of MS in the offspring (relative risk, 1.90; 95%CI, 1.20-3.01; P = .006)

compared with women who did not have deficient 25(OH)D levels. There was no statistically

significant association between the risk of MS and increasing serum 25(OH)D levels (P = .12).

CONCLUSIONS AND RELEVANCE Insufficient maternal 25(OH)D during pregnancymay

increase the risk of MS in offspring

Kokoelmat
  • Rinnakkaistallenteet [19207]

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste
 

 

Tämä kokoelma

JulkaisuajatTekijätNimekkeetAsiasanatTiedekuntaLaitosOppiaineYhteisöt ja kokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste